Thu-24-03-2016, 10:12 AM
They don't even need that research and development excuse now, I see hedge funds are buying pharmaceutical companies and jacking up the prices and saying take it or leave it ..
Germany says Cosentyx shows no added benefit for psoriatic arthritis.
|
« Next Oldest | Next Newest »
|
Possibly Related Threads… | |||||
Thread | Author | Replies | Views | Last Post | |
Bimzelx vs Skyrizi study for psoriatic arthritis | Fred | 0 | 521 |
Mon-30-09-2024, 14:22 PM Last Post: Fred |
|
Polymorphisms associated with Cosentyx | Fred | 6 | 2,968 |
Sun-07-01-2024, 11:01 AM Last Post: Caroline |
|
Bimzelx gets recommendation for psoriatic arthritis in the EU | Fred | 2 | 2,661 |
Sat-10-06-2023, 14:33 PM Last Post: Forest Walker |
|
Tremfya for psoriatic arthritis phase 3b data | Fred | 0 | 1,490 |
Wed-31-05-2023, 16:26 PM Last Post: Fred |
|
Bimzelx and psoriatic arthritis long term data | Fred | 0 | 1,587 |
Wed-31-05-2023, 14:00 PM Last Post: Fred |